SEPSIS MONOCLONALS WILL ACCOUNT FOR 11% OF RIVERSIDE METHODIST HOSPITAL's ANNUAL DRUG BILL WHEN APPROVED; USE GUIDES BEING DEVELOPED BEFORE FDA APPROVAL

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".